TickerFactsScreenerDevelopers

aTYR PHARMA INC (ATYR) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $644.0K2014: $249.0K2015: $664.0K2016: $600.0K2017: $1.31M2018: $594.0K2019: $79.0K2020: $202.0K2021: $192.0K2022: $1.64M2023: $4.21M2024: $65.0K2025: $77.0K$77.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$77.0K+18.5%
2024$65.0K-98.5%
2023$4.21M+156.9%
2022$1.64M+754.7%
2021$192.0K-5.0%
2020$202.0K+155.7%
2019$79.0K-86.7%
2018$594.0K-54.7%
2017$1.31M+118.7%
2016$600.0K-9.6%
2015$664.0K+166.7%
2014$249.0K-61.3%
2013$644.0K—